Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
19951000 citationsMunther A. Khamashta, María José Cuadrado et al.New England Journal of Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of F Mujić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Mujić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Mujić more than expected).
This network shows the impact of papers produced by F Mujić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Mujić. The network helps show where F Mujić may publish in the future.
Co-authorship network of co-authors of F Mujić
This figure shows the co-authorship network connecting the top 25 collaborators of F Mujić.
A scholar is included among the top collaborators of F Mujić based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Mujić. F Mujić is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
9 of 9 papers shown
1.
Aguirre, M. Á., Aurora Jurado, F Mujić, & M J Cuadrado. (1998). Oral anticoagulation therapy of chronic skin ulcers in a patient with primary antiphospholipid syndrome.. PubMed. 16(5). 628–9.1 indexed citations
Cuadrado, María José, F Mujić, Eduardo Muñóz, Munther A. Khamashta, & G. R. V. Hughes. (1997). Thrombocytopenia in the antiphospholipid syndrome. Annals of the Rheumatic Diseases. 56(3). 194–196.88 indexed citations
4.
D’Cruz, David, María José Cuadrado, F Mujić, et al.. (1997). Immunosuppressive therapy in lupus nephritis.. PubMed. 15(3). 275–82.59 indexed citations
5.
Khamashta, Munther A., María José Cuadrado, F Mujić, et al.. (1995). The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome. New England Journal of Medicine. 332(15). 993–997.1000 indexed citations breakdown →
6.
Mujić, F, María José Cuadrado, Mark Lloyd, et al.. (1995). Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.. PubMed. 22(8). 1589–92.35 indexed citations
7.
Mujić, F, Mark Lloyd, M J Cuadrado, M A Khamashta, & G R Hughes. (1995). Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome.. PubMed. 13(3). 327–31.11 indexed citations
Mujić, F, et al.. (1992). [Isoproterenol toxicity in the myocardium in an experiment].. PubMed. 43(1). 11–20.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.